Document is current
Any future updates will be listed below
-
Authors
Cursano, M. C.
Conteduca, V.
Scarpi, E.
Gurioli, G.
Casadei, C.
Gargiulo, S.
Altavilla, A.
Lolli, C.
Vincenzi, B.
Tonini, G.
Santini, D.
De Giorgi, U.
- License Information
-
More Information
Article History
Received: 22 January 2020
Accepted: 6 January 2021
First Online: 5 May 2022
Competing interests
: U. De Giorgi has received personal fees for advisory board/consultancy from Astellas, Bayer, BMS, Ipsen, Janssen, Merck, Novartis, Pfizer, Sanofi. V.Conteduca has received speaker honoraria or travel support from Astellas, Janssen-Cilag, and Sanofi-Aventis, and has received consulting fee from Bayer. G. Tonini has received personal fees for advisory board/consultancy from Novartis, Pfizer, Roche, Italfarmaco. Other authors declare no competing interest.
